Lag-times between lympho-proliferative disorder and clinical diagnosis of chronic lymphocytic leukemia (CLL): a prospective analysis using plasma soluble CD23. (Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2014)

(untitled) - Kaaks, R; Sookthai, D; Luczynska, A; Oakes, C; Becker, S; Johnson, T; Johansson, A; Melin, B; Sjöberg, K; Trichopoulos, D; Trichopoulou, A; Lagiou, P; et al.